Clinical Trial Update: A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of Copaxone (glatiramer acetate) and estriol in relapsing-remitting multiple sclerosis; results were posted after the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• COPAXONE (GLATIRAMER ACETATE)
• Estriol (estriol)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Relapsing Remitting Multiple Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2016-06-16